华鲁网群
综合内网 English
投资者关系
信息透明,信任同行
投资者关系
27
2025-06
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
27
2025-06
海外監管公告-關於獲得《藥品補充申請批准通知書》等相關情況的公告
19
2025-06
Overseas Regulatory Announcement- Announcement on the Completion of Enrollment of the First Patient in China for Phase II Clinical Trials of OAB-14 Dry Suspension
19
2025-06
海外監管公告-關於OAB-14幹混懸劑完成Ⅱ期臨床中國首例患者入組的公告
13
2025-06
Articles of Association
13
2025-06
公司章程
11
2025-06
Overseas Regulatory Announcement-Announcement on Sacubitril Valsartan Sodium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
11
2025-06
海外監管公告-關於獲得沙庫巴曲纈沙坦鈉化學原料藥上市申請批准通知書的公告
05
2025-06
Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Soft Capsules Having Obtained Drug Registration Certificate
05
2025-06
海外監管公告-關於取得二十碳五烯酸乙酯軟膠囊藥品註冊證書的公告
总条数: 67